InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: ziploc_1 post# 378418

Wednesday, 05/25/2022 7:45:22 AM

Wednesday, May 25, 2022 7:45:22 AM

Post# of 425933
z-

necessity for Amarin to drastically lower their prices for Vascepa

Wrong. The primary advantage of the generics is the lower Tier ... is not a significantly lower price. AG with the same list price as the brand will be cheaper for patients than the brand and most likely the difference of out-of-pocket between gV and AG will be minimal (if any).

Best,
G

Disclosure: I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.

Notice: This post is not investment advice, and not a recommendation to neither buy nor hold nor sell.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News